Doctor's dilemma: Incorporating tumor markers into clinical decision-making☆
To access this article, please choose from the options below
☆ Address reprint requests to Ian F. Tannock, MD, Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
PII: S0093-7754(02)50185-8
doi:10.1053/sonc.2002.32904
© 2002 Published by Elsevier Inc.
